Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001600-20Phase 2Terminated
Phase 2 trial of piritramide in chronic low back pain (CLBP), sponsored by Dr. Martin Pinsger & Univ.-Prof. Dr. Rupert Prokesch. Primary endpoint: Change in VAS pain score at 35 days. Started Aug 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001600-20.